Please login to the form below

Illumina

This page shows the latest Illumina news and features for those working in and with pharma, biotech and healthcare.

Illumina sets up first ex-US accelerator site in Cambridge

Boost for UK's golden triangle biotech region. Illumina has set up its first hub for genomics start-up funding outside the US, and has chosen Cambridge in the UK for ... harness the rapid and affordable next-generation sequencing technology pioneered by

Latest news

Grail’s multi-cancer blood test gets FDA breakthrough status

Grail is a spin-out of genome sequencing giant Illumina, and is leveraging the whole genome sequencing (WGS) power of its parent company with the goal of revolutionising cancer diagnostics.
Loxo, Bayer get FDA okay for biomarker-driven cancer drug

To try to address the diagnostic issue, Loxo formed a partnership earlier this year with Illumina to develop a simple test – called TruSight Tumour 170 – that will use sequencing to identify
UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen

There’s no question that ONT needs to build scale quickly if it is to take on the likes of Illumina, which reported sales of $2.75bn last year compared to ... is not as accurate or high-throughput as Illumina’s, and the latter will continue to
Loxo, Bayer get quick FDA review for ‘precision’ cancer drug

To try to address that issue, Loxo formed a partnership earlier this year with Illumina to develop a companion diagnostic – called TruSight Tumour 170 – that will use sequencing to identify whether
Daily Brief: Calls for early Brexit deal for science and innovation, Gottlieb threatens to name and shame

Genomics. Illumina buys genome data analysis firm. Genome sequencing leader Illumina has paid $100m for Edico Genome, a company which has developed software to speed-up the reading of genetic data. ... President of Product Development at Illumina.

More from news
Approximately 8 fully matching, plus 12 partially matching documents found.

Latest Intelligence

25 Women Leaders in UK Healthcare

centre run by Illumina, and an automated analytics platform to return whole genome analyses to the NHS.
Deal Watch January 2017

IBM Watson Health/ Illumina. Partnership to integrate Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumour sequencing process to expand access to genomic data.
Digital: Fallacy or the Future Face of Pharma Marketing?

Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
Pharma deals during July 2013

Roche, rumoured to be interested in Alexion, may still be smarting from the battle to try and take over Illumina last year.
What can pharma learn from Olympic sports coverage?

So where could Roche go next? With its unsuccessful takeover bid for Illumina, it could be a move into genetic sequencing to augment their oncology capability and more besides.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

Illumina expands board of directors

John Thompson brings experience from IBM and Microsoft. San Diego, US-based Illumina has appointed John Thompson to its board of directors. ... Francis de Souza, president and chief executive of Illumina, said: “John brings a great breadth of knowledge
GlobalData makes Americas appointment

He has spent 18 years in varous positions in the life sciences consulting industry, including roles at, Bionest Partners, IMS Management Consulting, and Illumina Inc.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Dan Coffin joins London Headquarters as Director

Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm.
Why is the UK lagging behind the rest of Europe in cancer survival?

To bring home the importance of this diagnostic technology, the CEO of Illumina (a top DNA sequencing firm) believes this technology will become the “ stethoscope for the next 200 years.” A

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Director – UK Office: Excellent salary and benefits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Events Executive: DOE

Senior Medical Writer: Competitive salary plus benefits

Account Manager – Healthcare advertising: Salary TBC

Client Services Director- Flexible Working: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Subscribe to our email news alerts

PMHub

Add my company

Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Report: Customer experience, shaping digital healthcare: In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D: The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it: What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...